AADX

Applied Aerospace & Defense, Inc.

NYSE · CIK 0002118195
$17.54 -5.70% $3.2B
Insider Buying Cluster (4 insiders)High Impact Filing (7/10)
Vol
Market Cap$3.2B
Cap SizeMid Cap
Insider Activity4B / 0S
Insider Net $$1.2M
Reddit Sentiment39° Cool
SEC Reports10
Exchange NYSE·CIK 0002118195·Prev Close $18.60

Recent Insider Trades

DateInsiderTypeValue
Jun 4, 2026Lynch SusanBUY$160.0K
Jun 4, 2026McRae JeffreyBUY$500.0K
Jun 4, 2026Goldstein ScottBUY$10.0K
Jun 4, 2026Goldstein ScottA$85.0K
Jun 4, 2026Katzman JamesBUY$500.0K

Reddit Sentiment

39°
Cool
Bearish Neutral Bullish
5 mentions 0 bullish 2 bearish

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

4 unique insiders with 4 transactions. Net insider value: $1.2M ($1.2M bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 4, 2026Lynch Susan DDirectorBUY8,000$20.00$160.0K
Jun 4, 2026McRae Jeffrey L.Chief Financial OfficerBUY25,000$20.00$500.0K
Jun 4, 2026Goldstein Scott (NMN)DirectorBUY500$20.00$10.0K
Jun 4, 2026Goldstein Scott (NMN)DirectorA4,250$20.00$85.0K
Jun 4, 2026Katzman James CDirectorBUY25,000$20.00$500.0K
Jun 4, 2026Katzman James CDirectorA4,250$20.00$85.0K

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

39°
Cool
Bearish Neutral Bullish
5 mentions 0 bullish 2 bearish 4 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 30, 2026250° Neutral002
May 30, 2026150° Neutral001
May 27, 2026140° Cool011
May 27, 2026140° Cool011

Recent Reddit Threads

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.